How to Handle a COVID-19 Vaccine-Related Adenopathy Seen on Breast MRI
Excerpt from the Article:
The Hospital of the University of Pennsylvania offers guidance – BI-RADS scoring and follow-up recommendations – for unilateral axillary lymphadenopathies seen on breast MRI in women who have received the vaccine.
The baseline breast MRI of a 48-year-old woman who has the BRCA1 mutation, as well as a strong family history of breast cancer, shows a unilateral left axillary lymphadenopathy with level 1 nodes that are asymmetric in size and number from her right breast. What do you do?
Based on recently published research, you should find out if she has received the COVID-19 vaccine. Then, you can determine how best to proceed.
Findings from Weill Cornell Medicine published in January revealed the likelihood of women who have received either the Moderna or Pfizner-BioNTech COVID-19 vaccines to develop unilateral axillary lymphadenopathies that mimic breast malignancies. The Society of Breast Imaging followed up shortly with guidance on how to handle these incidents when they are found on ultrasound or mammography.
Click the button below to read the entire Article:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?